Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News NeuroMetrix Inc NURO

Healthcare Medical Devices
NeuroMetrix, Inc. is a commercial-stage healthcare company that develops and commercializes neurotechnology devices to address unmet needs in the chronic pain and diabetes markets. The Company's products are wearable or hand-held medical devices enabled by proprietary consumables and software solutions that include mobile apps, enterprise software and cloud-based systems. The Company has two... see more

Recent & Breaking News (NDAQ:NURO)

NeuroMetrix Reports Strong Quell Demand in Q4 2016

Business Wire January 10, 2017

NeuroMetrix to Present at the Digital Medicine Showcase 2017: At the Intersection of Technology and Medicine

Business Wire January 6, 2017

NeuroMetrix Closes $7.0 Million Private Placement of Preferred Stock and Warrants

Business Wire January 5, 2017

NeuroMetrix to Present at Biotech Showcase 2017

Business Wire January 3, 2017

CES 2017: NeuroMetrix Brings Life-Enhancing Technology to Those Suffering from Chronic Pain

Business Wire January 3, 2017

NeuroMetrix Announces $7.0 Million Private Placement of Preferred Stock and Warrants

Business Wire December 28, 2016

NeuroMetrix Announces Participation in CES 2017

Business Wire December 22, 2016

NeuroMetrix Announces $26.5 Million Public Offering

Business Wire December 20, 2016

NeuroMetrix Reports Expanded Media Coverage for Quell Wearable Pain Relief

Business Wire December 15, 2016

NeuroMetrix Announces That Quell Is Featured in Huffington’s New Thrive Global Platform

Business Wire December 13, 2016

NeuroMetrix President and Chief Executive Officer Dr. Gozani to Speak at 2016 Connected Health Conference

Business Wire December 12, 2016

NeuroMetrix Announces Quell Now Available on Amazon.com through Amazon Launchpad

Business Wire December 7, 2016

NeuroMetrix to Present at the LD Micro Invitational Conference on December 6, 2016

Business Wire November 30, 2016

NeuroMetrix Receives CE Mark Certification for Quell Wearable Pain Relief Device

Business Wire November 29, 2016

NeuroMetrix Announces That Quell Will Be Featured on The Henry Ford Innovation Nation

Business Wire November 22, 2016

NeuroMetrix’ Quell Device Makes Second Appearance at American Society of Regional Anesthesia’s Annual Pain Medicine Meeting

Business Wire November 16, 2016

NeuroMetrix Reports DPNCheck Introduction at the Annual Meeting of the China Diabetes Society

Business Wire November 15, 2016

NeuroMetrix Chief Commercial Officer Frank McGillin to Present Quell Wearable Pain Relief Technology at 16th Annual Diabetes Technology Meeting

Business Wire November 10, 2016

NeuroMetrix Announces Promotion of Frank McGillin to Chief Commercial Officer

Business Wire November 8, 2016

NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Pain Relief Technology

Business Wire October 27, 2016